serine has been researched along with sorafenib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biondi, RM; Brieger, A; Hinrichsen, I; Huhn, M; Passmann, S; Plotz, G; Weßbecher, IM; Zeuzem, S | 1 |
| Chen, C; Deng, Q; Li, J; Shao, C; Shi, Z; Sun, H; Tang, W; Xiao, J; Xuan, Z; Ye, S; Yue, J; Zhang, L; Zhao, Y; Zheng, J; Zhu, F | 1 |
2 other study(ies) available for serine and sorafenib
| Article | Year |
|---|---|
Phosphorylation-dependent signaling controls degradation of DNA mismatch repair protein PMS2.
Topics: Blotting, Western; Enzyme Inhibitors; HEK293 Cells; Humans; Marine Toxins; Mismatch Repair Endonuclease PMS2; Mutation; MutL Protein Homolog 1; MutL Proteins; Niacinamide; Oxazoles; Phenylurea Compounds; Phosphorylation; Proteolysis; Serine; Signal Transduction; Sorafenib; Threonine | 2017 |
TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC.
Topics: Carcinoma, Renal Cell; Cell Transformation, Neoplastic; Humans; Kidney Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Serine; Sorafenib | 2022 |